$810 Million is the total value of SCOPIA CAPITAL MANAGEMENT LP's 37 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was - .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
New | FORTREA HLDGS INC | $31,125,304 | – | 1,088,678 | +100.0% | 3.84% | – | |
IWM | New | ISHARES TRput | $18,946,528 | – | 107,200 | +100.0% | 2.34% | – |
PEGA | New | PEGASYSTEMS INC | $10,194,708 | – | 234,847 | +100.0% | 1.26% | – |
AMD | New | ADVANCED MICRO DEVICES INC | $9,612,539 | – | 93,489 | +100.0% | 1.19% | – |
PI | New | IMPINJ INC | $878,169 | – | 15,958 | +100.0% | 0.11% | – |
LESL | New | LESLIES INC | $553,016 | – | 97,706 | +100.0% | 0.07% | – |
TPIC | New | TPI COMPOSITES INC | $175,096 | – | 66,074 | +100.0% | 0.02% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
SPIRIT AEROSYSTEMS HLDGS INC | 39 | Q4 2022 | 28.3% |
SPDR S&P 500 ETF TR | 31 | Q3 2023 | 16.9% |
ISHARES TR | 28 | Q3 2023 | 10.9% |
MANNKIND CORP | 24 | Q3 2023 | 0.5% |
BAIDU INC | 21 | Q2 2018 | 8.6% |
ITRON INC | 21 | Q3 2020 | 12.1% |
RETROPHIN INC | 20 | Q3 2020 | 4.5% |
HARMONIC INC | 19 | Q3 2023 | 10.5% |
JOHNSON CTLS INTL PLC | 17 | Q3 2020 | 9.6% |
ACORDA THERAPEUTICS INC | 17 | Q3 2019 | 4.0% |
View SCOPIA CAPITAL MANAGEMENT LP's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
VERRA MOBILITY Corp | October 28, 2022 | 6,710,074 | 4.4% |
Spirit AeroSystems Holdings, Inc. | February 14, 2022 | 2,084,212 | 2.0% |
Retrophin, Inc. | February 14, 2020 | 2,011,697 | 4.7% |
Horizon Therapeutics Public Ltd Co | January 10, 2020 | 2,527,456 | 1.4% |
ZOGENIX, INC. | January 10, 2020 | 919,484 | 2.1% |
ITRON, INC. | January 07, 2020 | 1,808,059 | 4.6% |
ACORDA THERAPEUTICS INCSold out | November 12, 2019 | 0 | 0.0% |
LA JOLLA PHARMACEUTICAL CO | April 10, 2019 | 480,000 | 1.8% |
Prothena Corp plc | March 11, 2019 | 1,883,816 | 4.7% |
GW PHARMACEUTICALS PLC | February 14, 2019 | 1,345,198 | 4.6% |
View SCOPIA CAPITAL MANAGEMENT LP's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
SC 13D | 2024-04-26 |
13F-HR | 2024-02-14 |
SC 13G | 2024-02-14 |
SC 13D/A | 2024-01-22 |
13F-HR/A | 2023-11-14 |
13F-HR | 2023-11-14 |
SC 13D | 2023-09-21 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
SC 13D/A | 2023-04-12 |
View SCOPIA CAPITAL MANAGEMENT LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.